Full Professor emeritus
Universitätsklinikum Jena
Jena, Thuringen, Germany
Prof. Hans R. Figulla MD is a retired professor at the Friedrich-Schiller-University Jena, Germany, and Director of the University Hospital Department for Internal Medicine I (Cardiology, Angiology, Intensive Care and Pneumology) from 1997 until 2015. He has published more than 500 papers in the field of dilated cardiomyopathy, cardiogenic shock and structural heart disease. He has invented multiple devices in interventional cardiology and is the founder of JenaValve Technology Inc., Occlutech GmbH and Cofounder of devie medical GmbH.
Tuesday, February 28, 2023
8:24 AM – 8:36 AM ET
Disclosure(s): devie medical GmbH: Officer or Board Member (Ongoing), Shareholder (Ongoing); JenaValve Technology Inc.: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Scientific Advisory Board (Ongoing); Occlutech Holding: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Shareholder (Ongoing); P+F Products and Features GmbH: Royalties (Ongoing)
Tuesday, February 28, 2023
9:54 AM – 10:02 AM ET
Disclosure(s): devie medical GmbH: Officer or Board Member (Ongoing), Shareholder (Ongoing); JenaValve Technology Inc.: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Scientific Advisory Board (Ongoing); Occlutech Holding: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Shareholder (Ongoing); P+F Products and Features GmbH: Royalties (Ongoing)
Tuesday, February 28, 2023
10:18 AM – 10:30 AM ET
Disclosure(s): devie medical GmbH: Officer or Board Member (Ongoing), Shareholder (Ongoing); JenaValve Technology Inc.: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Scientific Advisory Board (Ongoing); Occlutech Holding: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Shareholder (Ongoing); P+F Products and Features GmbH: Royalties (Ongoing)
Tuesday, February 28, 2023
10:30 AM – 10:38 AM ET
Disclosure(s): devie medical GmbH: Officer or Board Member (Ongoing), Shareholder (Ongoing); JenaValve Technology Inc.: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Scientific Advisory Board (Ongoing); Occlutech Holding: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Shareholder (Ongoing); P+F Products and Features GmbH: Royalties (Ongoing)